Cargando…
肺癌筛查方法现状
Lung cancer is the leading cause of cancer mortality currently. Early diagnosis is crucial to the good prognosis of lung cancer. Evidence has shown that low-dose computed tomography (CT) screening can make the decline in the mortality of lung cancer. However, there are still many problems in the scr...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973412/ https://www.ncbi.nlm.nih.gov/pubmed/27760605 http://dx.doi.org/10.3779/j.issn.1009-3419.2016.10.14 |
_version_ | 1783326625319878656 |
---|---|
collection | PubMed |
description | Lung cancer is the leading cause of cancer mortality currently. Early diagnosis is crucial to the good prognosis of lung cancer. Evidence has shown that low-dose computed tomography (CT) screening can make the decline in the mortality of lung cancer. However, there are still many problems in the screening, such as, high false-positive rates, overdiagnosis and radiation exposure. As another non-invasive tumor screening method, blood-based tumor markers showed a high sensitivity and specificity in early diagnosis of lung cancer in recent years. How to establish a comprehensive mode for lung cancer screening by use existing screening methods, we need more clinical research. |
format | Online Article Text |
id | pubmed-5973412 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | 中国肺癌杂志编辑部 |
record_format | MEDLINE/PubMed |
spelling | pubmed-59734122018-07-06 肺癌筛查方法现状 Zhongguo Fei Ai Za Zhi 综述 Lung cancer is the leading cause of cancer mortality currently. Early diagnosis is crucial to the good prognosis of lung cancer. Evidence has shown that low-dose computed tomography (CT) screening can make the decline in the mortality of lung cancer. However, there are still many problems in the screening, such as, high false-positive rates, overdiagnosis and radiation exposure. As another non-invasive tumor screening method, blood-based tumor markers showed a high sensitivity and specificity in early diagnosis of lung cancer in recent years. How to establish a comprehensive mode for lung cancer screening by use existing screening methods, we need more clinical research. 中国肺癌杂志编辑部 2016-10-20 /pmc/articles/PMC5973412/ /pubmed/27760605 http://dx.doi.org/10.3779/j.issn.1009-3419.2016.10.14 Text en 版权所有©《中国肺癌杂志》编辑部2016 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/ |
spellingShingle | 综述 肺癌筛查方法现状 |
title | 肺癌筛查方法现状 |
title_full | 肺癌筛查方法现状 |
title_fullStr | 肺癌筛查方法现状 |
title_full_unstemmed | 肺癌筛查方法现状 |
title_short | 肺癌筛查方法现状 |
title_sort | 肺癌筛查方法现状 |
topic | 综述 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973412/ https://www.ncbi.nlm.nih.gov/pubmed/27760605 http://dx.doi.org/10.3779/j.issn.1009-3419.2016.10.14 |